Skip to ContentSkip to Navigation
How to find us prof. dr. G.N. (Gert) Moll


LP2, the first lanthipeptide GPCR agonist in a human pharmacokinetics and safety study

An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium

Biosynthesis of lanthionine-constrained agonists of G protein-coupled receptors

Cyclic angiotensin-(1-7) contributes to rehabilitation of animal performance in a rat model of cerebral stroke

Does activation of the protective Renin-Angiotensin System have therapeutic potential in COVID-19?

High-throughput screening for substrate specificity-adapted mutants of the nisin dehydratase NisB

Efficacy of lanthionine-stabilized angiotensin-(1-7) in type I and type II diabetes mouse models

Genetically Encoded Libraries of Constrained Peptides

Mutagenesis of nisin's leader peptide proline strongly modulates export of precursor nisin

Phage display and selection of lanthipeptides on the carboxy-terminus of the gene-3 minor coat protein

Read more


Uit RUG voortgekomen Lanthio Pharma Chemische Start-up van het Jaar